Pro Nephro AKI (NGAL) is now FDA-Cleared     READ MORE

Investor News

BioPorto

BioPorto A/S

BioPorto announces Interim Result for the First Quarter of 2026

Thu, 21 May 2026 06:56 GMT

BioPorto

BioPorto A/S

Resolutions of the Annual General Meeting

Fri, 24 Apr 2026 14:22 GMT